Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Ted Downs who wrote (2617)	2/23/2000 9:31:00 AM
From: Phil Cressman	Read Replies (3) \| Respond to of 2742

I still believe that some insiders leaked information about this deal and that caused the resent runup. There are people who know a lot better than us what this deal will mean in dollars/share. Since this looks like a share transaction a lot may depend on the buyer's share price as well. Sure looks to me like we all know who the likely partner is and Cistron management helps no one by witholding this information. Personally I feel a share transaction that values Cistron less than $1.00 per share sucks.

To: Ted Downs who wrote (2617)	2/23/2000 11:44:00 AM
From: Walter Morton	Respond to of 2742

How did you come up with just $.66? Cistron is worth at least $3. This deal is pathetic!!!!

To: Ted Downs who wrote (2617)	2/28/2000 12:12:00 PM
From: Walter Morton	Respond to of 2742

Cistron Biotechnology is referenced in 18 patents owned by other companies. Of these, 9 have been issued in the last two years including: Chiron Corporation US05872095 02/16/1999 IL-1 receptor antagonists medicaments Chiron Corporation US05932537 08/03/1999 Method for attenuating a cellular response to IL-1 Chiron Corporation US05747444 05/05/1998 Method of treating graft-versus-host disease Chiron Corporation US05817306 10/06/1998 Method for treating graft versus host disease Chiron Corporation US05814469 09/29/1998 Method for diagnosing endometrial cancer Chiron Corporation US05840496 11/24/1998 Method for diagnosing endometrial cancer Chiron Corporation US05824549 10/20/1998 Transformed human T cell Pfizer Inc., US05739279 04/14/1998 Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents Cellcor, Inc., US05766920 06/16/1998 Ex vivo activation of immune cells